Bloomage BioTechnology Corporation Limited (SHA:688363)
China flag China · Delayed Price · Currency is CNY
39.52
-0.48 (-1.20%)
May 21, 2026, 3:00 PM CST

SHA:688363 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
1,004994.98719.271,1691,6061,807
Trading Asset Securities
60.9633.2930.02140.04530.72846.89
Cash & Short-Term Investments
1,0651,028749.291,3092,1372,654
Cash Growth
56.34%37.23%-42.75%-38.75%-19.47%25.58%
Accounts Receivable
608.02566.78547.38450.19457.87402.22
Other Receivables
46.7742.2645.2739.4251.9128.9
Receivables
654.79609.05592.65489.61509.78431.12
Inventory
929.58980.621,2481,1351,162709.13
Other Current Assets
212.54167.05150.96189.99214.93190.37
Total Current Assets
2,8622,7852,7413,1234,0233,984
Property, Plant & Equipment
4,0404,0904,2033,6572,9132,305
Long-Term Investments
603.73570.13585.02502.99592.63400.32
Goodwill
171.02177.62174.09251.28247.2267.15
Other Intangible Assets
512.22517.62490.63496.97475.06467.26
Long-Term Deferred Tax Assets
336.14335.56355.56336.98302.59246.11
Long-Term Deferred Charges
149.69155.12100.3498.14116.4331.85
Other Long-Term Assets
75.6561.937.513.6311.51.44
Total Assets
8,7508,6938,6578,4708,6827,504
Accounts Payable
602.07140.14195.41186.78247.75243.55
Accrued Expenses
145.23368.78587.09479.49672.75704.09
Short-Term Debt
160.0892.8949.92-139.2-
Current Portion of Long-Term Debt
100.6364.9328.89106.0836.5436.46
Current Portion of Leases
-49.3962.7947.0553.6749.61
Current Income Taxes Payable
70.838.7213.8555.6876.43135.52
Current Unearned Revenue
70.4457.7763.4855.5867.7450.83
Other Current Liabilities
62.07407.39339.6290.13349.97180.46
Total Current Liabilities
1,2111,1901,3411,2211,6441,401
Long-Term Debt
68.7494.6665.122.32107.97144.18
Long-Term Leases
64.8739.51152.9752.6652.4269.77
Long-Term Unearned Revenue
242.3248.94253.24205.73188.68182.71
Long-Term Deferred Tax Liabilities
3.134.244.575.095.664.12
Total Liabilities
1,5901,5771,8171,4871,9991,801
Common Stock
481.68481.68481.68481.68481.09480
Additional Paid-In Capital
3,8503,8503,8533,8413,7533,569
Retained Earnings
3,0042,9402,7002,7082,4091,674
Treasury Stock
-219.95-219.95-219.95-105.88--
Comprehensive Income & Other
14.1234.65-4.3219.57-9.1-23.91
Total Common Equity
7,1307,0866,8106,9446,6345,699
Minority Interest
29.8429.4929.6339.3349.213.45
Shareholders' Equity
7,1607,1156,8406,9836,6835,702
Total Liabilities & Equity
8,7508,6938,6578,4708,6827,504
Total Debt
394.32341.38359.69208.1389.79300.01
Net Cash (Debt)
670.31686.9389.61,1011,7472,354
Net Cash Growth
147.76%76.31%-64.60%-37.00%-25.77%12.67%
Net Cash Per Share
1.421.430.802.283.624.87
Filing Date Shares Outstanding
461.82478.36478.36480.26481.09480
Total Common Shares Outstanding
461.82478.36478.36480.26481.09480
Working Capital
1,6501,5951,4001,9022,3792,584
Book Value Per Share
15.4414.8114.2414.4613.7911.87
Tangible Book Value
6,4476,3906,1456,1965,9115,165
Tangible Book Value Per Share
13.9613.3612.8512.9012.2910.76
Buildings
-2,4772,4961,7561,3851,269
Machinery
-2,2601,7941,4101,148812.35
Construction In Progress
-438.52640.981,109830.45516.72
Source: S&P Global Market Intelligence. Standard template. Financial Sources.